Cargando…
New Therapeutic Approaches for Conjunctival Melanoma—What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells
Conjunctival melanoma (CM) accounts for 5% of all ocular melanomas and arises from malignantly transformed melanocytes in the conjunctival epithelium. Current therapies using surgical excision in combination with chemo- or cryotherapy still have high rates for recurrences and metastatic disease. Lat...
Autores principales: | Peil, Jennifer, Bock, Felix, Kiefer, Friedemann, Schmidt, Rebecca, Heindl, Ludwig M., Cursiefen, Claus, Schlereth, Simona L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835854/ https://www.ncbi.nlm.nih.gov/pubmed/35163401 http://dx.doi.org/10.3390/ijms23031478 |
Ejemplares similares
-
Impact of the Prolymphangiogenic Crosstalk in the Tumor Microenvironment on Lymphatic Cancer Metastasis
por: Schlereth, Simona L., et al.
Publicado: (2014) -
Transient Ingrowth of Lymphatic Vessels into the Physiologically Avascular Cornea Regulates Corneal Edema and Transparency
por: Hos, Deniz, et al.
Publicado: (2017) -
Intravital Two-Photon Microscopy of Immune Cell Dynamics in Corneal Lymphatic Vessels
por: Steven, Philipp, et al.
Publicado: (2011) -
What we know so far
Publicado: (2021) -
Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021)